Manufacturing

Our solid dosage manufacturing facility combines high production capacity with flexible manufacturing capabilities across a broad range of pharmaceutical products. Our advanced manufacturing lines can simultaneously process: 1,000 kg of granules, million tablets per hour, 400,000 capsules per hour. This provides an annual production capacity of 7.5 billion tablets and 1.2 billion capsules.

Solid Packaging

Solid dosage products manufactured at our main facility - including tablets, capsules and powder formulations - are packaged using 8 blister packaging lines, 2 bottle filling lines, and 1 sachet filling line. Our fully integrated packaging lines encompass Primary Packaging, Cartoning, 100% Automated Weight Inspection, Serialization, Case Packing These technologies ensure the highest standards of product safety, traceability and packaging integrity.

We manufacture the following solid dosage forms:

Our injectable ampoule and vial products are manufactured in aseptic production areas designed to meet the highest safety standards, using advanced manufacturing technologies and state-of-the-art equipment.

Our annual production capacity includes 14 million ampoules ranging from 1 mL to 10 mL and 9 million vials ranging from 2 mL to 100 mL, all manufactured under sterile conditions.

Cephalosporin Manufacturing

Cephalosporin products are manufactured in a fully segregated production facility, independent from our main manufacturing operations, ensuring complete operational separation. In addition to sterile cephalosporin products, the facility manufactures non-sterile solid dosage forms including Tablets, Film-Coated Tablets, Capsules, and Oral Suspensions. Annual manufacturing capacity includes non-sterile Cephalosporins, 4 million units of oral suspensions, 5 million units of tablets and capsules, Sterile Cephalosporins, 8 million injectable vials.